태국에서 유입된 유비저 사례와 미생물검사실 직원 노출자의 위험 분류 및 노출 후 예방조치 = Melioidosis from Thailand and Risk Classification and Precautionary Measures for Laboratory Staff who were Exposed

다국어 초록 (Multilingual Abstract)

Melioidosis is an infectious disease caused by Burkholderia pseudomallei, a Gram-negative bacillus, with a fatality rate of 14-49%. They are mainly exposed to contaminated soil or water through wounds, mucosa, inhalation, and ingestion. In addition, the exposure of healthcare workers (HCWs) participating in sample handling in the laboratory may occur. Herein, we report a case of melioidosis and introduce infection control guidelines for laboratory exposure. A 45-year-old male patient, a travel agent who resided in Chiang Mai, Thailand, and had uncontrolled diabetes, visited the hospital with a fever for 1 month. Initial laboratory study suggested systemic infection (C-reactive protein 259.8 mg/L, white blood cell 16,500/mm3), and liver abscess was identified in abdominal computed tomography (CT). Blood cultures identified Gram-negative bacilli, and B. pseudomallei was confirmed using 16s rRNA sequencing. Ceftazidime and doxycycline were administered, and the symptoms improved. The patient was discharged with trimethoprim-sulfamethoxazole treatment for 3 months. Ten laboratory staff handled the contaminated samples without proper protective personal equipment. Through risk classification, they were classified into the low-risk group and were monitored without postexposure prophylaxis for 21 days, and none of the patients developed any symptoms. Therefore, it is recommended to classify laboratory exposures to B. pseudomallei according to risk classification, monitor symptoms, and provide appropriate post-exposure prophylaxis.

참고문헌 (Reference)

• 1 Limmathurotsakul D, "Risk factors for recurrent melioidosis in northeast Thailand" 43 : 979-986, 2006
• 2 Smith MD, "Quantitative recovery of Burkholderia pseudomallei from soil in Thailand" 89 : 488-490, 1995
• 3 Yabuuchi E, "Proposal of Burkholderia gen. nov. and transfer of seven species of the genus Pseudomonas homology group II to the new genus, with the type species Burkholderia cepacia (Palleroni and Holmes 1981)comb. nov" 37 : 335-, 1993
• 4 Sivalingam SP, "Pre-and post-exposure prophylaxis of experimental Burkholderia pseudomallei infection with doxycycline, amoxicillin/clavulanic acid and co-trimoxazole" 61 : 674-678, 2008
• 5 Cheng AC, "Melioidosis: epidemiology, pathophysiology, and management" 20 : 533-, 2007
• 6 Mays EE, "Melioidosis : recrudescence associated with bronchogenic carcinoma twenty-six years following initial geographic exposure" 68 : 261-263, 1975
• 7 Wiersinga WJ, "Melioidosis" 367 : 1035-1044, 2012
• 8 White NJ, "Melioidosis" 361 : 1715-1722, 2003
• 9 Bennett JE, "Mandell, Douglas, and Bennett’s principles and practice of infectious diseases Vol. 2" Elsevier Saunders 2541-2551, 2015
• 10 Peacock SJ, "Management of accidental laboratory exposure to Burkholderia pseudomallei and B. mallei" 14 : e2-, 2008
• 11 Kingston CW, "Chronic or latent melioidosis" 2 : 618-621, 1971
• 12 CDC, "CDC web sites on Travelers Health. CDC Yellow Book"
• 13 Chantratita N, "Antimicrobial resistance to ceftazidime involving loss of penicillin-binding protein 3 in Burkholderia pseudomallei" 108 : 17165-17170, 2011
• 14 Whitmore A, "A hitherto undescribed infective disease in Rangoon" 47 : 262-267, 1912
• 15 Lee SY, "A case with melioidosis after traveling to Angkor Wat, Cambodia" 12 : 2-6, 2019